Madrigal Pharmaceuticals files Form 8-K
Madrigal Pharmaceuticals filed a Form 8-K on November 3.
Related stories
Mexico’s Main Stock Index Extends Gains Above 2%
M impact | EQUITY | Nov 03, 2026, 03:28 PM UTC
Sportradar Group Reports Third-Quarter Revenue of EUR362.5M
M impact | EQUITY | Nov 03, 2026, 03:28 PM UTC
BBVA Places CHF 290 Million Green Bond
BBVA placed CHF 290 million in a two-tranche senior preferred green bond issuance.
L impact | EQUITY | Nov 03, 2026, 03:28 PM UTC
NexPoint Residential Trust Reports Quarterly Results
NexPoint Residential Trust reported results for the quarter ended September 30.
M impact | EQUITY | Nov 03, 2026, 03:27 PM UTC
Mazda North American October Sales Total 31,446 Vehicles
M impact | EQUITY | Nov 03, 2026, 03:26 PM UTC
Sysco CEO Says Restaurant Traffic and Operator Volume Softened in August
Sysco’s CEO said restaurant traffic and restaurant operator volume softened during August.
L impact | EQUITY | Nov 03, 2026, 03:26 PM UTC